Allowing Fear to Dictate Cancer Treatment Decisions

Fear

  Last week saw the publication of a study on ductal carcinoma in situ. It engendered a lot of mixed messages as I wrote about here.  Following on from that study, also last week (August 27, 2015) the New York Times published an Op-Ed piece from Dr. Lisa Rosenbaum entitled, Let Fear Guide Early Stage Breast-Cancer Decisions. A version of this same article was printed in the New York edition with a similar, but slightly …

     

And We Wonder Why Patients Get Confused…

1020px-S10-5263_H&E_20x_DCIS

How often have we heard people lament about the inherent contradictions in cancer research? How often do people throw up their arms and say “I don’t know what to believe anymore”. Too many people harbour the feeling that whatever some study shows today will be contradicted by a study published next month and so on and so on. What too many folks fail to appreciate is that this is actually science and research working as …

     

Of “Ground-Breaking” and “Breakthrough” and “Blockbuster”: Endpoints Matter

Breakthrough

This week in San Diego the American Association for Cancer Research is holding its annual meeting. When I was an active cancer researcher this was one of the premier meetings that I made sure I attended if at all possible. The meeting itself is high enough profile that many top researchers from around the world wait to announce significant results at this meeting, because they know that the rest of the cancer research world will …